Synthetic peptide (gastric-derived)
A stable gastric pentadecapeptide studied for tissue-repair pathways.
At a glance
Overview
Synthetic 15-amino-acid sequence derived from a protein in gastric juice.
Widely studied in model systems for tendon, ligament, muscle and gut healing.
Mechanism
Proposed to modulate angiogenesis, growth-factor signalling and the nitric-oxide system to promote healing; exact human mechanism unconfirmed.
Research
Vasireddi N, et al. · American Journal of Sports Medicine · 2025 · Systematic review
Screened 544 articles on orthopaedic BPC-157; only one clinical study met inclusion criteria, the rest preclinical. Concludes the compound is promising preclinically but essentially unproven in humans for tendon/joint healing.
Józwiak M, et al. · Pharmaceuticals · 2025 · Systematic review
Maps the breadth of proposed applications while flagging that most literature originates from a small cluster of overlapping author groups, limiting generalisability.
Sikiric P, et al. · Pharmaceuticals · 2025 · Review
The originating research group's detailed defence of BPC-157's angiogenic and NO-system mechanisms; useful as the strongest "case for" argument.
Lee E, et al. · Alternative Therapies in Health and Medicine · 2024 · Clinical
Intravesical BPC-157 in 12 interstitial-cystitis patients with reported symptom improvement; small, uncontrolled and conflict-of-interest limited.
Lee & Burgess · Alternative Therapies in Health and Medicine · 2025 · Clinical
IV infusion up to 20 mg tolerated in two adults with no adverse events; establishes basic tolerability only.
Evidence summary
Backed by one of the most extensive preclinical research bases of any peptide, with remarkably consistent tissue-repair findings across numerous animal models. Early human pilot studies are now emerging, and it's currently under active FDA compounding review - a promising and fast-developing area of research.